iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report)’s share price traded down 3.6% during trading on Tuesday. The company traded as low as $30.30 and last traded at $30.30. Approximately 625 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 2,293 shares. The stock had previously closed at $31.43.
iShares Neuroscience and Healthcare ETF Price Performance
The firm’s 50 day moving average is $36.56 and its 200 day moving average is $36.07. The company has a market capitalization of $6.14 million, a PE ratio of 15.61 and a beta of 0.80.
About iShares Neuroscience and Healthcare ETF
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.
Featured Stories
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
